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Abstract  
BACKGROUND: Periodontal disease has been and will be a challenge for dentists in the entirety of oral 
pathologies. To date, there is no data regarding the prescription of antibiotics for periodontitis in the district of 
Tirana.  
AIM: Evaluate aspects related to the pattern of prescription of antibiotics among dentists in Tirana region for 
periodontitis. 
METHODS: Prescriptions from dental practitioners were collected from 25 pharmacies, randomly selected. The 
only prescription containing a diagnosis of periodontitis, with at least one antibiotic given, was included in the 
study. Data analysis was done with SPSS 20. 
RESULTS: Out of 1159 initial prescriptions, only 314 met the selection criteria. The average age of patients was 
39.91 ± 15.21 years. Mean duration of therapies was 5.57 ± 1.5 days. The most common form of prescription was 
one broad-spectrum antibiotic (74.5%), combined antibiotics therapy (22.3%) and narrow-spectrum antibiotic 
(3.2%). Combined antibiotics involved the use of Metronidazole with Amoxicillin (12.1%) and Metronidazole with 
Spiramycin (10.2%). Significant differences in the patterns of prescription were identified in relation with patient 
age and therapy duration (P < 0.05). No statistical difference was found in the patient’s gender and the typology of 
the therapy (P > 0.05). 
CONCLUSIONS: Our study shows prescription characteristics of antibiotics for periodontal disease by dentists in 
Tirana for the first time. Amoxycillin is the most prescribed antibiotic, followed by amoxicillin with clavulanic acid. 
We found variation in dosage, frequency and duration for all antibiotics used, and perceptible discrepancies 
between observed and recommended practice. Guidelines on rational antibiotic use are needed for dental 
practitioners in Tirana and the Republic of Albania for better management of periodontitis and resistance 
prevention. 
 
 
 
 
 
 
Introduction 
 
Periodontitis is an inflammatory disease which 
affects the supporting tissues of the tooth. It 
constitutes one of the most frequent bacterial infection 
in adults. There are hundreds of bacterial species 
associated with this disease, thus making it difficult to 
achieve a successful specific therapy for periodontitis 
[1]. Among these the most relevant are 
Aggregatibacter actinomycetemcomitans (A.a.), 
Porphyromonas gingivalis (P. gingivalis), Treponema 
denticola (T. denticola), Fusobacterium nucleatum (F. 
nucleatum) and Prevotella intermedia (P. intermedia), 
[2] [3] [4]. P. gingivalis is considered as the main 
cause of chronic periodontitis, though no less 
important is the A.a., which is recognised as the 
leading cause of aggressive periodontitis [2] [5] [6]. 
Difficulties faced by periodontists lie in the fact that the 
restoration of normality for the periodontal tissues 
becomes difficult with time. If left untreated, it can 
progress into an irreversible situation [7]. There are 
some procedures and protocols aimed to prevent the 
progression of the lesion, maintain current levels of 
periodontal tissues and restore periodontal health. To 
succeed in these procedures, in addition to manual 
curettage and periodontal surgery, systemic antibiotic 
therapy is a key factor [8] [9] [10] [11]. Strong 
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evidence exists to support benefits of manual 
curettage to remove supra and subgingival plaque. 
Hence, without the use of antibiotics, this procedure is 
unable to eradicate pathogenic bacterial species and 
thus to maintain gingival levels of adhesion [8] [12] 
[13]. To support such procedures, except 
monotherapy with antibiotics, dental practitioners use 
a combination of antibiotics known as a combined 
therapy or dual antibiotic therapy [14] [15] [16]. 
To the best of our knowledge, to date, there is 
no data regarding the prescription of antibiotics for 
periodontitis in the region of Tirana. 
 
 
Materials and Methods 
 
This retrospective drug utilisation study was 
conducted over a period of 3 months, March-June 
2016. It involved prescriptions collected from 25 
randomly selected pharmacies in the region of Tirana. 
We collected prescriptions dispensed by dentists and 
selection criteria included prescriptions: (a) limited and 
only for periodontitis in patients ≥18 years old; and (b) 
with at least one antibiotic prescribed. Prescriptions 
with other systemic drugs or local medications were 
excluded from the study.  
Collected data were analysed using the 
statistical software SPSS 20 (IBM, USA). Differences 
between patterns of prescription, patient's age, gender 
and treatment duration were compared using One-
way ANOVA and Chi-square tests. P-values < 0.05 
were considered statistically significant. 
 
 
Results 
 
From 1159 collected prescriptions, only 314 
met the selection criteria. The gender ratio was 1:1.12 
consisting of 148 Males (47.1%) and 166 Females 
(52.9%). The average age was 39.91 ± 15.21years 
(18-81). Mean duration of therapies was 5.57 ± 1.5 
days (3-10) (Table 1).  
Table 1: Age and therapy duration variables parameters 
 
Age of patients Duration of therapy 
Mean 39.91 5.57 
Median 36.00 5.00 
Mode 25 5 
Standard deviation 15.21 1.50 
Minimum 18 3 
Maximum 81 10 
 
Three patterns of antibiotic prescription were 
observed: (a) 74.5% single therapies with a broad-
spectrum antibiotic (BSA), (b) 22.3% combined 
therapies (CT) consisting in a broad-spectrum 
antibiotic and a narrow-spectrum antibiotic and (c) 
3.2% narrow-spectrum antibiotic (NSA) (Table 2). 
Table 2: Frequency of type of antibiotic therapies 
The pattern of antibiotic prescription Value % 
Broad spectrum  234 74.5 
Broad and narrow spectrum combination 70 22.3 
Narrow spectrum  10 3.2 
 
Among 234 BSA prescriptions, Amoxicillin is 
the most prescribed drug (32,5%), followed by 
Amoxicillin-Clavulanic Acid (22%) and Spiramycin 
(12.7%). Instead, Erythromycin (4.1%), Azithromycin 
(1.6%) and Ciprofloxacin (1.6%) are less prescribed 
drugs. CT involved the use of Amoxicillin with 
Metronidazole (12.1%) and Spiramycin with 
Metronidazole (10.2%). Regarding the use of NSA, 
only Metronidazole was prescribed (Table 3).  
Table 3: Percentage of antibiotic prescription and 
characteristics of therapy duration 
Antibiotic 
 
Therapy duration (days) 
% Mean Maximum Minimum Mode 
Broad spectrum 
     
Amoxycillin 32.5 5 7 3 5 
Amoxycillin with Clavulanic Acid 22 5 7 3 5 
Spiramycin 12.7 5 7 3 5 
Erythromycin 4.1 5 6 3 5 
Ciprofloxacin 1.6 5 7 4 4 
Azithromycin 1.6 5 5 5 5 
Mixed spectrum 
 
   
 Metronidazole+Amoxycillin 
w/Clavulanic Acid 
12.1 7 10 6 7 
Metronidazole+Spiramycin 10.2 8 10 5 7 
Narrow spectrum 
     Metronidazole 3.2 6 7 6 6 
 
One-way ANOVA test indicated the 
statistically significant difference between the three 
typologies of antibiotic therapy prescribed, patient's 
age and treatment duration (Table 4).  
Table 4: One Way ANOVA test results for patients age and 
treatment duration about the type of therapy 
 
Sum of 
Squares 
df Mean Square F Sig. 
Age 3106.280 2 1553.140 6.962 0.001 
Treatment 
duration 
399.900 2 199.950 201.206 0.000 
 
Post Hoc test demonstrated that the single 
BSA therapy and CT do not show significant 
differences in mean patients age, while NS therapy 
presented significant difference compared with both 
therapies (Table 5).  
Table 5: Multiple comparisons where the dependent variable is 
patient age 
(I) Antibiotic 
type 
(J) Antibiotic type 
Mean 
Differenc
e (I-J) 
Std. 
Error 
Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Broad 
spectrum 
antibiotic  
Combined therapy 1.469 2.035 .751 -3.32 6.26 
Metronidazole 17.912
*
 4.823 .001 6.55 29.27 
Combined 
therapy 
Broad spectrum antibiotic -1.469 2.035 .751 -6.26 3.32 
Metronidazole 16.443
*
 5.049 .004 4.55 28.33 
Narrow 
spectrum 
antibiotic 
Broad spectrum antibiotic -17.912
*
 4.823 .001 -29.27 -6.55 
Combined therapy -16.443
*
 5.049 .004 -28.33 -4.55 
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Data shows that NSA like Metronidazole 
tends to be prescribed to younger patients with a 
mean age of 23 years (Figure 1).  
 
Figure 1: Mean patients age  
 
Furthermore, Post Hoc test showed the 
statistically significant difference between all three 
types of antibiotic therapies regarding the duration of 
therapies (Table 6).  
Table 6: Multiple comparisons where the dependent variable is 
therapy duration 
(I) Antibiotic 
type 
(J) Antibiotic type 
Mean 
Differenc
e (I-J) 
Std. 
Error 
Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Broad 
spectrum 
antibiotic 
Combined therapy -2.705
*
 0.136 0.000 -3.03 -2.39 
Metronidazole -1.377
*
 0.322 0.000 -2.14 -0.62 
Combined 
therapy 
Broad spectrum 
antibiotic 
2.705
*
 0.136 0.000 2.39 3.03 
Metronidazole 1.329
*
 0.337 0.000 .53 2.12 
Narrow 
spectrum 
antibiotic 
Broad spectrum 
antibiotic 
1.377
*
 0.322 0.000 .62 2.14 
Combined therapy -1.329
*
 0.337 0.000 -2.12 -0.53 
 
The single broad-spectrum antibiotic regime 
has a mean duration of 4.92 days while Metronidazole 
therapy for 5 days. Dual therapy has the longest 
regimen, with a mean of 7.63 days (Figure 2). 
 
Figure 2: Mean therapy duration 
 
No statistical difference was found in the 
patient’s gender and the typology of the therapy (P > 
0.05). 
Discussion 
 
This study shows that dentists in the Tirana 
region tend to prescribe BSA in 74.5% of cases. 
Amoxicillin alone and its combination with Clavulanic 
acid are prescribed in more than half of cases 
(54.5%). Amoxicillin is found to be useful in the 
management of patients with aggressive periodontitis, 
in both localised and generalised forms [17] [18]. Also, 
its combination with Clavulanate potassium shows to 
incline bacterial resistance. Also, Spiramycin is 
frequently used. In 12.7% of prescription, it is used 
alone for the management of periodontal disease. 
Spiramycin has shown promising results in the 
treatment of advanced forms of periodontitis, and as 
an adjunct to thorough scaling and root planning, 
provides a statistically significant improvement in 
probing depths for up to 24 weeks when compared 
with scaling and root planing alone. Furthermore, it 
produces a significant improvement in attachment 
level [18] [19] [20] [21]. 
On the other hand, NSA alone, such as 
Metronidazole remains a non-primary choice for the 
pharmacological treatment of periodontal disease, 
with only 3.2% of prescriptions. Although, the 
literature shows that Metronidazole has a prominent 
effect on periodontitis, yet there is scepticism among 
dentists who are reluctant to prescribe it. However, 
Metronidazole alone it’s not the drug of choice for 
treating A.a. infections. Instead, it’s a combination with 
other antibiotics shows to be effective against these 
bacteria [22] [23]. Also, it is effective against 
anaerobes such as P. gingivalis and P. intermedia 
[24]. Studies have suggested that Metronidazole 
combined with Amoxicillin or Amoxicillin–Clavulanate 
potassium, it may be with great impact in the 
management of patients with aggressive periodontitis 
[23] [25] [26] [27] [28]. In our study, Metronidazole 
was mostly used in combination with Amoxicillin 
12.1% and with Spiramycin in 10.2%. Of the cases. 
Clinical research suggests that Ciprofloxacin 
with Metronidazole is a powerful antibiotic 
combination against mixed infections. At present, 
Ciprofloxacin is the only antibiotic in periodontal 
therapy to which all strains of A.a. are susceptible [29] 
[30] [31] [32]. Metronidazole targets obligate 
anaerobes, and Ciprofloxacin targets facultative 
anaerobes. This type of therapy can be of great 
benefit for the patients since periodontal infections 
contain a wide diversity of bacteria, and this scenario 
makes it mandatory to use more than one antibiotic, 
either serially or in combination [33] [34] [35] [36] [37]. 
Nevertheless, data shows that dentists in Tirana 
region do not use this combination. 
The duration of the treatment shows to be a 
problem itself, with a mean of 5.57 ± 1.5 days. 
Dentists who prescribe only one antibiotic, prefer a 5-
days therapy. In contrast, dentists that have chosen a 
combination therapy have prescribed it for a longer 
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time, and this can be the case of chronic resistant 
periodontitis. Only the CT has a mean duration of 7.63 
days. None of the prescriptions had a prolonged 
therapy for more than ten days. Therapies with BSA, 
have a mean duration of 4.92 days and a therapy with 
NSA has a mean duration of 6.3 days. This is a short-
term therapy which may pose a risk regarding 
antibiotic resistance rather than a successful 
treatment for the disease. This, especially in cases of 
chronic periodontitis where the presence of 
periodontal pathogens, specifically A.a., is known to 
endure in tissues after therapy and re-infect the 
pocket. Thus, the use of systemic antibiotics was 
thought to be necessary to eliminate pathogenic 
bacteria from the tissues [27]. 
Interpretation of the processed data, not only 
does show that NSA like Metronidazole have a limited 
number of prescriptions, but it is more used in young 
adults. Patients with a generalised form of the disease 
usually appear to be young, and they present 
generalised attachment loss and poor antibody 
response. Therefore, these patients often have a fair, 
poor, or questionable prognosis, and they need an 
effective systemic antibiotics therapy. This is in 
contrast with our findings of NSA use in younger 
adults.  
Evidence shows that there is a lack of 
knowledge for antibiotic prescription patterns and 
duration of therapy in dentists in the region of Tirana. 
The increasing resistance problems of recent years 
are probably related to the over-or misuse of 
antibiotics. There is a clear need for the development 
of prescribing guidelines and educational initiatives to 
encourage the rational and appropriate use of 
antibiotics in dentistry, especially periodontal 
problems. These are issues we found to be present 
also in other countries [38] [39] [40] [41] [42] [43] [44]. 
While the use of antibiotics in periodontal 
treatment will probably always be controversial, the 
position paper of the American Academy of 
Periodontology contains valuable guidance for their 
use, and we would recommend their application in 
everyday practice by dentists. Following exhaustive 
literature searches, this paper determined that 
patients with aggressive periodontitis appear to 
benefit from the adjunctive use of systemic antibiotics 
during treatment. Systemic antibiotic therapy helps the 
manual curettage and improves immune response to 
eliminate subgingival bacteria, which are not affected 
by manual therapy [12]. The mechanical curettage 
without the addition of systemic antibiotics would 
probably be a failure considering the rapid bacterial 
colonisation of periodontal pockets [36]. 
Based on WHO latest report, antimicrobial 
resistance poses a "global health security threat" to 
public health [45]. Subsequently, to benefit the most 
from these therapies, we must limit their use and 
prescribe the right dosage and duration of therapy to 
prevent further resistance. 
In conclusion, our study shows prescription 
characteristics of antibiotics for periodontal disease by 
dentists in Tirana for the first time. Most of the dentist 
in the district of Tirana, for periodontitis, prescribes 
only one broad-spectrum antibiotic. Amoxicillin was 
the most preferable, followed by amoxicillin with 
clavulanic acid. Metronidazole a narrow spectrum 
antibiotic is prescribed more in young adults, while 
combined therapies and broad-spectrum antibiotics 
tend to be prescribed with the increasing of patient’s 
age. We found variations in dosage and frequency for 
all the antibiotics used, particularly concerning data 
exists regarding the short duration of therapies 
prescribed. Perceptible discrepancies were observed 
between recommendations and practice. Therefore, 
these observations highlight the need for dentists to 
improve antibiotic prescribing practices for periodontal 
problems. Guidelines on rational antibiotic use are 
needed for dental practitioners in Tirana and in the 
Republic of Albania for a better management of 
periodontitis and resistance prevention. 
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